Related Experiment Video

Updated: Aug 11, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Chemokine polymorphisms: candidates for MS susceptibility and disease course

A Achiron1

  • 1Multiple Sclerosis Centre, Sheba Medical Centre, Tel-Hashomer, Israel. achqzron@sheba.health.gov.il

International MS Journal
|December 9, 2004
PubMed

Insights

Polymorphic genes, particularly chemokines and their receptors, are emerging as key factors in multiple sclerosis (MS) susceptibility. Understanding these genetic elements is crucial for unraveling the autoimmune inflammatory response in MS.

Area of Science:

  • Neuroimmunology
  • Genetics of autoimmune diseases

Background:

  • Multiple sclerosis (MS) involves complex autoimmune inflammatory responses.
  • Genetic factors play a significant role in MS susceptibility and resistance.
  • Chemokines and their receptors are critical in inflammatory processes and cell trafficking.

Purpose of the Study:

  • To explore the role of polymorphic genes in MS.
  • To investigate chemokines and their receptors as candidate loci in MS aetiology.
  • To understand the contribution of chemokine-mediated inflammation to MS pathogenesis.

Main Methods:

  • Genetic analysis of polymorphic genes.
  • Identification and characterization of chemokine and receptor variants.
  • Correlation of genetic findings with MS disease status.

Main Results:

  • Polymorphic genes involved in autoimmune responses are potential MS susceptibility factors.
  • Chemokines and their receptors show promise as candidate loci for MS.
  • Chemokines' role in inflammation and CNS trafficking supports their involvement in MS.

Conclusions:

  • Genetic variations in immune response genes, especially chemokines, are important in MS.
  • Further research into chemokine genetics is warranted for understanding MS aetiology.
  • Chemokine system dysregulation may contribute to MS pathogenesis.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...